Occlutech International Ab

This study is testing a device called the Occlutech Atrial Flow Regulator in 150 people with chronic heart failure. The device is implanted to help balance pressure in the heart's chambers, potentially reducing symptoms and hospital stays. Researchers will track safety and heart-…

This program allows people with heart failure to receive Occlutech's atrial flow regulator (AFR) under the FDA's Expanded Access program. The AFR is a device implanted in the heart to help manage fluid buildup and improve symptoms. This is not a cure, but aims to control the dise…

This study looks at a device called the Occlutech PDA Occluder, which is used to close a heart defect called patent ductus arteriosus (PDA). The defect is a small blood vessel that should close after birth but stays open, causing extra strain on the heart. The device is placed th…

This study follows about 50 people of any age who receive a special device to close a hole in the muscular part of the heart's lower chambers. The device is placed through a tube in a blood vessel, avoiding open-heart surgery. Researchers will check for serious side effects and c…

This study follows 685 people who receive heart implants using special Occlutech tools. Doctors will fill out surveys to track how well the tools work and if any problems happen during or after the procedure. The goal is to make sure these tools are safe and easy to use.